Publikationen von Michael W. Sereda

Wessig, C.; Jestaedt, L.; Sereda, M. W.; Bendszus, M.; Stoll, G.: Gadofluorine M-enhanced magnetic resonance nerve imaging: Comparison between acute inflammatory and chronic degenerative demyelination in rats. Experimental Neurology 210 (1), S. 137 - 143 (2008)

Nave, K.-A.; Sereda, M. W.; Ehrenreich, H.: Mechanisms of Disease: inherited demyelinating neuropathies - from basic to clinical research. Nature Clinical Practice Neurology 3 (8), S. 453 - 464 (2007)

Ivanova, N.; Claeys, K. G.; Deconinck, T.; Litvinenko, I.; Jordanova, A.; Auer-Grumbach, M.; Haberlova, J.; Löfgren, A.; Smeyers, G.; Nelis, E. et al.; Mercelis, R.; Plecko, B.; Priller, J.; Zamecnik, J.; Ceulemans, B.; Erichsen, A. K.; Björck, E.; Nicholson, G.; Sereda, M. W.; Seeman, P.; Kremensky, I.; Mitev, V.; De Jonghe, P.: Hereditary spastic paraplegia 3A associated with axonal neuropathy. Archives of Neurology 64 (5), S. 706 - 713 (2007)

Meyer zu Hörste, G.; Prukop, T.; Liebetanz, D.; Möbius, W.; Nave, K.-A.; Sereda, M. W.: Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy. Annals of Neurology 61 (1), S. 61 - 72 (2007)

Meyer zu Hörste, G.; Prukop, T.; Nave, K.-A.; Sereda, M. W.: Myelin disorders: causes and perspectives of Charcot-Marie-Tooth neuropathy. Journal of Molecular Neuroscience 28 (1), S. 77 - 88 (2006)

Sereda, M. W.; Nave, K.-A.: Animal models of Charcot-Marie-Tooth disease type 1A. Neuromolecular Medicine 8 (1-2), S. 205 - 215 (2006)

Vigo, T.; Nobbio, L.; Van Hummelen, P.; Abbruzzese, M.; Mancardi, G. L.; Verpoorten, N.; Verhoeven, K.; Sereda, M. W.; Nave, K.-A.; Timmerman, V. et al.; Schenone, A.: Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis. Molecular and Cellular Neuroscience 28 (4), S. 703 - 714 (2005)

Meyer zu Hörste, G.; Sereda, M. W.: Genetische Defekte der Myelinbildung: Molekulare Pathogenese der Charcot-Marie-Tooth Neuropathie (CMT1A). Neuroforum 1, S. 25 - 30 (2005)

Grandis, M.; Leandri, M.; Vigo, T.; Cilli, M.; Sereda, M. W.; Gherardi, G.; Benedetti, L.; Mancardi, G.; Abbruzzese, M.; Nave, K.-A. et al.; Nobbio, L.; Schenone, A.: Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. Experimental Neurology 190 (1), S. 213 - 223 (2004)

Michailov, G. V.; Sereda, M. W.; Brinkmann, B. G.; Fischer, T. M.; Haug, B.; Birchmeier, C.; Role, L.; Lai, C.; Schwab, M. H.; Nave, K.-A.: Axonal Neuregulin-1 Regulates Myelin Sheath Thickness. Science 304 (5671), S. 700 - 703 (2004)

Sereda, M. W.; Meyer zu Hörste, G.; Suter, U.; Uzma, N.; Nave, K.-A.: Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nature Medicine 9 (12), S. 1533 - 1537 (2003)

Schneider, S.; Bosse, F.; D'Urso, D.; Müller, H.-W.; Sereda, M. W.; Nave, K.-A.; Niehaus, A.; Kempf, T.; Schnölzer, M.; Trotter, J.: The AN2 Protein Is a Novel Marker for the Schwann Cell Lineage Expressed by Immature and Nonmyelinating Schwann Cells. The Journal of Neuroscience 21 (3), S. 920 - 933 (2001)

Schwab, M. H.; Sereda, M. W.; Nave, K.-A.: Neuron-glial interactions: Schwann cells. In: Patterning and cell type specification developing CNS and PNS: Comprehensive developmental neuroscience, Chapter 44 Aufl., S. 851 - 869 (Hg. Rubenstein, J. L.; Rakic, P.). Elsevier, Amsterdam [et al.] (2013)